CD44+ circulating tumour cells (CTCs) in patients with gastric cancer were also shown to correlate with the clinicopathologic characteristics of the resected tumour specimens, including disease stage and venous invasion, whilst CD44− CTCs did not (Watanabe et al., 2017). This evidence concerns the gene CD44 and gastric cancer.